Zhengye Biotechnology opens at $3.77, IPO priced at $4.00
Zhengye Biotechnology, a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in China, priced its initial public offering of 1.5M shares at a public offering price of $4.00. The shares are listed on the Nasdaq under the ticker symbol "ZYBT." Kingswood Capital Partners is acting as the sole book-running manager for the offering.
